Ryan Mordue

Ryan Mordue

Auto-generated profile, based on publicly available information

Ryan Mordue

MRC Toxicology Unit, University of Cambridge, Tennis Court Road, Cambridge CB2 1QR, UK

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2022 in Molecular Cell
Verified
Journal Article
Open access
MSMark Stoneley
Mark Stoneley
RHRobert F. Harvey
Robert F. Harvey
TMThomas E. Mulroney
Thomas E. Mulroney
RMRyan Mordue
Ryan Mordue
RJRebekah Jukes-Jones
Rebekah Jukes-Jones
AWAnne E Willis
Anne E Willis
During the translation surveillance mechanism known as ribosome-associated quality control, the ASC-1 complex (ASCC) disassembles ribosomes stalled on the mRNA. Here, we show that there are two distinct classes of stalled ribosome. Ribosomes stalled by translation elongation inhibitors or methylated mRNA are short lived in human cells because they are split by the ASCC. In contrast, although ultraviolet light and 4-nitroquinoline 1-oxide induce ribosome stalling by damaging mRNA, and the ASCC is recruited to these stalled ribosomes, we found that they are refractory to the ASCC. Consequently, unresolved UV- and 4NQO-stalled ribosomes persist in human cells. We show that ribosome stalling activates cell-cycle arrest, partly through ZAK-p38MAPK signaling, and that this cell-cycle delay is prolonged when the ASCC cannot resolve stalled ribosomes. Thus, we propose that the sensitivity of stalled ribosomes to the ASCC influences the kinetics of stall resolution, which in turn controls the adaptive stress response.